Oramed Pharmaceuticals Inc (ORMP)
2.33
0.00 (0.00%)
USD |
NASDAQ |
Nov 14, 16:00
2.33
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| February 28, 2019 | 91.74% |
| November 30, 2018 | 94.81% |
| August 31, 2018 | |
| May 31, 2018 | |
| February 28, 2018 | |
| November 30, 2017 | |
| August 31, 2017 |
| Date | Value |
|---|---|
| May 31, 2017 | |
| February 28, 2017 | |
| November 30, 2016 | 69.34% |
| August 31, 2016 | -35.41% |
| May 31, 2016 | 95.09% |
| February 29, 2016 | 96.80% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Skye Bioscience Inc | -- |
| Scilex Holding Co | 73.18% |
| NovaBay Pharmaceuticals Inc | 65.26% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |